词条 | Thromboxane B2 |
释义 |
| Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 428769862 | ImageFile=Thromboxane B2.svg | ImageSize=250px | ImageFileL2=ThromboxaneB2 spacefill.png | ImageFileR2=ThromboxaneB2.png | IUPACName= | OtherNames= |Section1={{Chembox Identifiers | CASNo_Ref = {{cascite|correct|??}} | CASNo=54397-85-2 | PubChem=5283137 | ChEBI_Ref = {{ebicite|changed|EBI}} | ChEBI = 28728 | SMILES= CCCCC[C@H](O)\\C=C\\[C@H]1OC(O)C[C@H](O)[C@@H]1C\\C=C/CCCC(O)=O | MeSHName=Thromboxane+B2 |Section2={{Chembox Properties | Formula=C20H34O6 | MolarMass=370.48 g/mol | Appearance= | Density= | MeltingPt= | BoilingPt= | Solubility= |Section3={{Chembox Hazards | MainHazards= | FlashPt= | AutoignitionPt = }} Thromboxane B2 is an inactive metabolite/product of thromboxane A2. It is almost completely cleared in the urine. It itself is not involved in platelet activation and aggregation in case of a wound, but its precursor, thromboxane A2, is. Thromboxane A2 synthesis is the target of the drug aspirin, which inhibits the COX-1 enzyme (the source of thromboxane A2 in platelets). [1] 2-(3,4-Di-hydroxyphenyl)-ethanol (DHPE) is a phenolic component of extra-virgin olive oil. An olive oil fraction containing DHPE can inhibit platelet aggregation and thromboxane B2 formation in vitro.[2]References1. ^{{cite web |url=http://cancerweb.ncl.ac.uk/cgi-bin/omd?thromboxane+b2 |title=Definition: thromboxane b2 from Online Medical Dictionary |format= |work= |accessdate=2008-11-02}} {{Eicosanoids}}2. ^Inhibition of platelet aggregation and eicosanoid production by phenolic components of olive oil. Anna Petroni, Milena Blasevich, Marco Salami, Nadia Papini, Gian F. Montedoro and Claudio Gallia, Thrombosis Research, 15 April 1995, Volume 78, Issue 2, Pages 151–160, {{doi|10.1016/0049-3848(95)00043-7}} 1 : Eicosanoids |
随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。